Paid demo
Feel adaptive resistance for yourself.
15-minute hands-on session against the Alpha and Omni force curves. Demo fee is refunded against the first machine purchase.
Why operators run paid demos
Strength outcomes are dose-response. The demo lets you feel the dose-response threshold ARX hits in 15 minutes — and validate whether it integrates with your clinical protocol or member experience.
Underlying evidence
- Dalleck 2021 RCT: Equivalent strength gains in less than half the time-on-machine vs. conventional resistance training.(verification pending)
- AEL meta-analysis: Accentuated-eccentric loading drives greater hypertrophy and strength adaptation per session than concentric-only protocols.(verification pending)
- GLP-1 muscle-loss cohort: Adaptive resistance preserves lean mass during GLP-1 weight loss when other modalities can't reach the dose-response threshold.(verification pending)
- Time-efficiency studies: Two 15-minute sessions per week reach the strength dose-response threshold required for clinical outcomes.(verification pending)
- Nuzzo 2023 CARE framework: The eccentric phase of adaptive resistance is mechanistically distinct from concentric-only loading; the dose-response advantage compounds across joint integrity, hypertrophy and strength.(verification pending)
- Once-Weekly Eccentric protocol: Once-weekly eccentric protocols reach the dose-response threshold that conventional 3x/week routines target — the time-efficiency story for HNW and busy clinical buyers.(verification pending)
- Oldest-old strength outcomes: Adaptive resistance produces meaningful strength and balance gains in the 80+ cohort where fall-prevention ROI is most measurable on incident rates and downstream care costs.(verification pending)
- JAMA Network Open GLP-1 muscle loss: Patients on semaglutide / tirzepatide retain lean mass at meaningfully lower rates than non-GLP-1 weight-loss cohorts; structured resistance is the documented mitigation.(verification pending)
- Galiano 2024 sarcopenia review: Resistance-based intervention slows sarcopenia progression in HRT-cohort patients; bone density outcomes correlate with adherence to dose-response strength protocols.(verification pending)
- Delphi Consensus — longevity protocols: Expert consensus on the role of dose-response resistance training in longevity protocols — the strength dose is the consensus floor under which other longevity interventions underperform.(verification pending)
- Resistance training & mortality: Sustained resistance training is independently associated with reduced all-cause mortality; the time-efficient delivery model preserves the effect at lower compliance burden.(verification pending)
- Mayo clinical adoption white paper: Clinical adoption framework documents reimbursement-pathway and operator-economics models for adaptive resistance integration in integrated medical practice.(verification pending)
Common questions
Why is the demo paid?
ARX is $43,000–$46,000 capital equipment with deal-cycle attention from a small specialist team. The paid demo signals real evaluation intent + lets the ARX team prepare ICP-specific clinical or commercial materials in advance. The fee is fully refunded against the first machine purchase, so it's effectively a deposit on the proposal call rather than a charge.
What does the demo cover?
A 15-minute hands-on session on the Alpha and Omni force curves so you feel adaptive resistance + eccentric overload directly, plus a 30-minute review of clinical or commercial fit (ICP-specific protocol templates, ROI assumptions for your facility size, installation logistics). Peer-facility outcome data is brought to the call when relevant to your segment.
How long does the discovery flow take from first contact to demo?
Typical timeline: same-day reply to your booking → demo scheduled within 5-10 business days at your nearest partner facility (or virtual within 3-5 days) → 30-min discovery call same week as the demo → proposal within 7 days of the discovery call. Full evaluation cycle for most buyers is 3-5 weeks; longer for institutional buyers requiring committee review.
In-person or virtual demo?
In-person at the nearest partner facility is preferred — feeling adaptive resistance is the demo and the ROI of the demo fee scales with the hands-on time. Virtual video demos are available when no nearby facility exists, paired with the same 30-minute clinical/commercial fit review afterward.
What are the time-on-machine claims based on?
Peer-reviewed adaptive-resistance + accentuated-eccentric-loading literature. The 15-minute / 28-minute-per-week claim is rooted in Dalleck 2021 (15-min ARX vs. 45-min traditional comparison group with superior outcomes) and Scientific Reports 2024 (once-weekly eccentric training producing measurable strength + power gains). Full citations + open-access links live at science.arxfit.com.
Does ARX integrate with clinical protocols?
Yes — longevity, regenerative, weight-loss (GLP-1), hormone replacement and integrated-medical clinics use ARX as the strength-protocol arm of their care plan. Session data exports to EMR / SFTP. The Medical Professional page covers protocol templates by clinical-segment and the GLP-1 muscle-preservation integration spec.
Who's on the demo + discovery call?
The demo is delivered by a partner-facility operator + an ARX clinical specialist (Kyle on the operator side, Ryan on the protocol + close side). For institutional buyers, an additional implementation contact joins the discovery call to scope installation timeline + training logistics.
Can I bring my team or stakeholders to the demo?
Yes. Most clinical demos include 2-3 stakeholders (clinical lead + operator + sometimes a CFO or research partner). Send participant names + roles when booking so the ARX team can prepare the right cross-section of materials.